112 Results

People

  1. Jarnagin
    Jarnagin
  2. D'Angelica
    D'Angelica
  3. Gonen
    Gonen
  4. DeMatteo
    DeMatteo
  5. Fong
    Fong
  6. Blumgart
    Blumgart
  7. Kemeny
    Kemeny
  8. Allen
    Allen
  9. Motzer
    Motzer
  10. Capanu
    Capanu

Groups

  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (58)
  3. Center for Pancreatic Cancer Research (31)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (30)
  6. Surgery (29)
  7. Gastrointestinal Oncology Service (26)
  8. Radiology, Department of (19)
  9. Center for Hematologic Malignancies (17)
  10. Hematologic Malignancies, Division of (17)
  1. "bilirubin blood level"
Formats
  1. Journal Article (110)
  2. Review (2)
Groups
  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (58)
  3. Center for Pancreatic Cancer Research (31)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (30)
  6. Surgery (29)

More Groups

People
  1. William Jarnagin (16)
  2. Michael D'Angelica (14)
  3. Mithat Gonen (14)
  4. Nancy Kemeny (14)
  5. Ronald DeMatteo (12)
  6. Yuman Fong (12)

More People

Years
  1. 2025 (7)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer (7)
  3. Lancet Oncology (7)
  4. Clinical Cancer Research (5)
  5. HPB (4)
  6. Journal of the American College of Surgeons (4)

More Publications

Publishers
  1. Elsevier Science, Inc. (20)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (12)
  4. Wiley Blackwell (12)
  5. Springer (10)
  6. American Association for Cancer Research (6)

More Publishers

Results (112)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Broadening eligibility criteria to make clinical trials more representative: American Society of Clinical Oncology and Friends of Cancer Research joint research statement
    Journal Article

    Kim, E. S.; Bruinooge, S. S.; Roberts, S.; Ison, G.; Lin, N. U.; Gore, L.; Uldrick, T. S.; Lichtman, S. M.; Roach, N.; Beaver, J. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): A multicentre, single-arm, phase 2 study
    Journal Article

    Balar, A. V.; Castellano, D.; O'Donnell, P. H.; Grivas, P.; Vuky, J.; Powles, T.; Plimack, E. R.; Hahn, N. M.; de Wit, R.; Pang, L.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Anthracyclines in early breast cancer: The ABC trials - USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
    Journal Article

    Blum, J. L.; Flynn, P. J.; Yothers, G.; Asmar, L.; Geyer, C. E., Jr.; Jacobs, S. A.; Robert, N. J.; Hopkins, J. O.; O’Shaughnessy, J. A.; Dang, C. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial
    Journal Article

    Balar, A. V.; Galsky, M. D.; Rosenberg, J. E.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Statins and survival outcomes in patients with metastatic renal cell carcinoma
    Journal Article

    McKay, R. R.; Lin, X.; Albiges, L.; Fay, A. P.; Kaymakcalan, M. D.; Mickey, S. S.; Ghoroghchian, P. P.; Bhatt, R. S.; Kaffenberger, S. D.; Simantov, R.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Fatal hepatitis B reactivation in a patient with islet cell tumor on octreotide and sirolimus
    Journal Article

    DeFilippis, E. M.; Ludwig, E.
    Journal of Gastrointestinal Oncology (2015)

    Fulltext@MSK | Save
  • Individualized risk estimation for postoperative complications after surgery for oral cavity cancer
    Journal Article

    Awad, M. I.; Palmer, F. L.; Kou, L.; Yu, C.; Montero, P. H.; Shuman, A. G.; Ganly, I.; Shah, J. P.; Kattan, M. W.; Patel, S. G.
    JAMA Otolaryngology - Head and Neck Surgery (2015)

    Fulltext@MSK | Save
  • Randomized multicenter phase II study of modified docetaxel, cisplatin, and fluorouracil (DCF) versus DCF plus growth factor support in patients with metastatic gastric adenocarcinoma: A study of the US gastric cancer consortium
    Journal Article

    Shah, M. A.; Janjigian, Y. Y.; Stoller, R.; Shibata, S.; Kemeny, M.; Krishnamurthi, S.; Bernard, Su, Y.; Ocean, A.; Capanu, M.; Mehrotra, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save